• Info
  • Insider Ownership

Insider Trading & Ownership of Kenneth J. Hillan

Location
Richmond, CA
Summary
The estimated net worth of Kenneth J. Hillan is at least $205K dollars as of 16 Jun 2025. Kenneth J. Hillan is the Chief Therapeutics Officer of 23andMe Holding Co. and owns shares of 23andMe Holding Co. (MEHCQ) stock worth about $159K. Kenneth J. Hillan is the Director of SANGAMO THERAPEUTICS, INC and owns shares of SANGAMO THERAPEUTICS, INC (SGMO) stock worth about $45.8K.
Signature
/s/ Prathyusha Duraibabu, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Kenneth J. Hillan files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kenneth J. Hillan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MEHCQ 23andMe Holding Co. Chief Therapeutics Officer $159K 05 Jun 2023
SGMO SANGAMO THERAPEUTICS, INC Director $45.8K 12 Jun 2025
ZYME Zymeworks BC Inc. Director 06 May 2021
ZYME Zymeworks Inc. Director 07 Dec 2023

Insider Transactions Reported by Kenneth J. Hillan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.